Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Arzneimittel-Forschung|August 1, 1996
Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiolI Setnikar, L C Rovati, B Vens-Cappell, et al.Arzneimittel-Forschung|June 1, 1987
Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dogI Setnikar, R Arigoni, R Chisté, et al.Arzneimittel-Forschung|March 1, 1996
Bioavailability of estradiol from two transdermal patchesI Setnikar, L C Rovati, B Vens-Cappell, et al.Regulatory Peptides|August 17, 1987
Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogsP Hildebrand, C Beglinger, E Köhler, et al.Arzneimittel-Forschung|September 1, 1989
Antispasmodic activity of tiropramideI Setnikar, R Cereda, M A Pacini, et al.British Journal of Pharmacology|April 1, 1987
Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestineL Barthó, P Holzer, F Lembeck, et al.Arzneimittel-Forschung|October 29, 2000
Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patchA Santoro, L C Rovati, I Setnikar, et al.Arzneimittel-Forschung|September 1, 1989
Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramideI Setnikar, R Cereda, M A Pacini, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 6, 1998
Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphateJ D Ringe, A Dorst, C Kipshoven, et al.Arzneimittel-Forschung|April 1, 1986
Pharmacokinetics of tiropramide after single doses in manR Arigoni, R Chisté, A Drovanti, et al.Pageof 8